ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,599.30
0.49%
Dow Jones
41,350.93
-0.20%
US Dollar vs MXN
20.18335
0.02%
Brent Oil
70.625
-0.09%
Bitcoin
83,833.77
0.19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE

  6. Ginkgo Bioworks Holdings Inc (DNA) Cotización

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

Donaco International Ltd
6.65
-0.29
(-4.18%)
Cerrado 12 Marzo 2:00PM
Delayed by 15 minutes
6.83
0.18
(2.71%)
Fuera de horario: 5:40PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
6.83
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
1,488,582
6.615 Rango del Día 7.34
5.26 Rango de 52 semanas 49.20
Capitalización de Mercado [m]
396.369M
Precio Anterior
6.94
Precio de Apertura
7.23
Hora
10
@
6.8287
Última hora de negociación
Volumen financiero
US$ 10,229,546
Precio Promedio Ponderado
6.872
Volumen promedio (3 m)
1,742,471
Acciones en circulación
58,033,600
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.43
Beneficio por acción (BPA)
-15.39
turnover
251.46M
Beneficio neto
-892.87M

Acerca de Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Sector
Biological Pds,ex Diagnstics
Industria
Blank Checks
Sitio web
www.ginkgobioworks.com
Sede
Wilmington, Delaware, USA
Fundado
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker DNA. The last closing price for Ginkgo Bioworks was US$6.94. Over the last year, Ginkgo Bioworks shares have traded in a share price range of US$ 5.26 to US$ 49.20.

Ginkgo Bioworks currently has 58,033,600 shares in issue. The market capitalisation of Ginkgo Bioworks is US$402.75 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.43.

DNA Últimas noticias

Más noticias

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
12 horas hace
DNA (-4.18%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
11 Marzo 2025
DNA (-4.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
10 Marzo 2025
DNA (-4.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
10 Marzo 2025
DNA (-4.18%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
10 Marzo 2025
DNA (-4.18%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
07 Marzo 2025
DNA (-4.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Marzo 2025
DNA (-4.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Marzo 2025
DNA (-4.18%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
27 Febrero 2025
DNA (-4.18%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.5-18.00720288128.338.46.58513414607.49366475CS
4-5.14-42.940685045911.9715.966.585210261410.21869625CS
12-2.93-30.02049180339.7616.856.585174247111.04840157CS
260.538.41269841276.316.856.0114896009.68675363CS
52-41.97-86.004098360748.849.25.262181311622.7434281CS
156-115.17-94.4016393443122196.45.262236683465.92345691CS
260-442.77-98.4808718861449.6634.565.262064308984.71128275CS

DNA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ginkgo Bioworks?
El precio actual de las acciones de Ginkgo Bioworks es US$ 6.83
¿Cuántas acciones de Ginkgo Bioworks están en circulación?
Ginkgo Bioworks tiene 58,033,600 acciones en circulación
¿Cuál es la capitalización de mercado de Ginkgo Bioworks?
La capitalización de mercado de Ginkgo Bioworks es USD 402.75M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ginkgo Bioworks?
Ginkgo Bioworks ha negociado en un rango de US$ 5.26 a US$ 49.20 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ginkgo Bioworks?
El ratio precio/beneficio de Ginkgo Bioworks es -0.43
¿Cuál es el ratio de efectivo a ventas de Ginkgo Bioworks?
El ratio de efectivo a ventas de Ginkgo Bioworks es 1.53
¿Cuál es la moneda de reporte de Ginkgo Bioworks?
Ginkgo Bioworks presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Ginkgo Bioworks?
El último ingresos anual de Ginkgo Bioworks es USD 251.46M
¿Cuál es el último beneficio anual de Ginkgo Bioworks?
El último beneficio anual de Ginkgo Bioworks es USD -892.87M
¿Cuál es la dirección registrada de Ginkgo Bioworks?
La dirección registrada de Ginkgo Bioworks es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Ginkgo Bioworks?
La dirección del sitio web de Ginkgo Bioworks es www.ginkgobioworks.com
¿En qué sector industrial opera Ginkgo Bioworks?
Ginkgo Bioworks opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FTKFlotek Industries Inc
US$ 8.745
(18.02%)
556.69k
IONQIonQ Inc
US$ 21.82
(16.68%)
27.26M
CXMSprinklr Inc
US$ 9.42
(16.58%)
7.01M
SEISolaris Energy Infrastructure Inc
US$ 25.27
(13.68%)
2.96M
CHGGChegg Inc
US$ 0.8678
(12.42%)
3.12M
DTCSolo Brands Inc
US$ 0.2431
(-62.89%)
6.94M
HLLYHolley Inc
US$ 2.45
(-17.79%)
1.12M
MATVMativ Holdings Inc
US$ 5.86
(-14.70%)
3.92M
CNFCNFinance Holdings Limited
US$ 0.8701
(-14.70%)
87.4k
NOVASunnova Energy International Inc
US$ 0.3662
(-13.86%)
38.27M
FFord Motor Company
US$ 9.59
(-1.03%)
129.96M
NIONIO Inc
US$ 5.105
(-2.20%)
87.31M
QBTSD Wave Quantum Inc
US$ 5.87
(9.11%)
72.81M
TAT&T Inc
US$ 25.72
(-1.11%)
62.38M
NUNu Holdings Ltd
US$ 10.895
(2.78%)
51.72M

DNA Discussion

Ver más
Monksdream Monksdream 2 semanas hace
DNA 10Q due TUEsday 2/25
👍️0
Monksdream Monksdream 4 semanas hace
DNA still climbing
👍️ 1
Monksdream Monksdream 1 mes hace
DNA
👍️0
ItsMyOption ItsMyOption 2 meses hace
DNA just hit over sold area $8.70 that is .22 before the 1:40 R/S should go back up $11.00 soon
👍️0
Monksdream Monksdream 3 meses hace
DNA under $10
👍️0
Monksdream Monksdream 3 meses hace
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 3 meses hace
cheap
👍️0
Monksdream Monksdream 5 meses hace
DNA under $10
👍️0
Monksdream Monksdream 5 meses hace
DNA 10 day hourly post reverse split
👍️0
hwang_jini hwang_jini 6 meses hace
Cascade (Gates) top holder
👍️0
Monksdream Monksdream 6 meses hace
DNA new. 52 w eek low
👍️0
Monksdream Monksdream 6 meses hace
DNA new 52/week low
👍️0
Monksdream Monksdream 6 meses hace
DNA new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
DNA new 52 week low
👍️0
ItsMyOption ItsMyOption 7 meses hace
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 7 meses hace
DNA new 52 low
👍️0
Dingbatt Dingbatt 7 meses hace
Interesting stock bought a few for tracking
To see what the crawdads do
👍️0
ItsMyOption ItsMyOption 7 meses hace
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
👍️0
hwang_jini hwang_jini 7 meses hace
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
👍️0
Acme Investments Acme Investments 8 meses hace
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
👍️0
Acme Investments Acme Investments 9 meses hace
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 9 meses hace
😂😂😂😂😂😂😂
👍️0
trade2brich trade2brich 9 meses hace
ARK dumped all holdings. I am out. Cut my losses.
👍️0
Monksdream Monksdream 9 meses hace
It will reverse split because there is no choice
👍️0
JohnnyBlaze JohnnyBlaze 9 meses hace
Average down or cut losses?
👍️0
Monksdream Monksdream 9 meses hace
DNA new 52 week low
👍️0
Acme Investments Acme Investments 9 meses hace
Timber!!
👍️0
JohnnyBlaze JohnnyBlaze 9 meses hace
Bought a few
👍️0
Acme Investments Acme Investments 9 meses hace
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 9 meses hace
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
👍️0
Monksdream Monksdream 9 meses hace
DNA new 52 week low
👍️0
Stump Jumper Stump Jumper 9 meses hace
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
👍️0
philaya philaya 9 meses hace
Got in low...
Bounce ready.
👍️0
ItsMyOption ItsMyOption 9 meses hace
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
👍️0
Stump Jumper Stump Jumper 9 meses hace
Is this the bottom?
👍️0
Acme Investments Acme Investments 9 meses hace
Acknowledge Me!! Lol 😂
👍️0
wiredawg wiredawg 10 meses hace
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
👍️0
Monksdream Monksdream 10 meses hace
DNA new 52 week low
👍️0
Acme Investments Acme Investments 10 meses hace
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
👍️0
Acme Investments Acme Investments 10 meses hace
Still happy??
👍️0
ItsMyOption ItsMyOption 10 meses hace
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
👍️0
Acme Investments Acme Investments 10 meses hace
Hope you took profits!! They just wanted to burn the shorts!!
👍️0
Acme Investments Acme Investments 10 meses hace
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
👍️0
trade2brich trade2brich 10 meses hace
Bought at .70….up 30%
👍️0
Acme Investments Acme Investments 10 meses hace
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
👍️0
trade2brich trade2brich 10 meses hace
ARK bought 12 million shares on Friday
👍️0
Acme Investments Acme Investments 10 meses hace
Ark is like the cattle whisperer!! Slaughter awaits!!
👍️0
Monksdream Monksdream 11 meses hace
DNA new 52 week low
👍️0
Monksdream Monksdream 11 meses hace
Aren’t you the smart one

👍️0
trade2brich trade2brich 11 meses hace
I did not I keep buying
👍️0

Su Consulta Reciente

NYSE
DNA
Ginkgo Bioworks
CSE
TERA
Terra Balcanica Resources
BIT
BZU
Buzzi
NASDAQ
LBGJ
Li Bang
TG
ARRA
Arcelormittal
BIT
UB5171
Unicredit Bank
BIT
P06568
Vontobel Financial Produ...
NASDAQ
CCBG
Capital City Bank
TSXV
QCX
QCX Gold
BIT
UC78PC
Unicredit Bank
AMEX
IBHH
ishares ibonds 2028 Term...
USOTC
ONCI
On4 Communications (PK)
FX
HKDKRW
HKD vs KRW
CSE
CDPR
Cerro de Pasco Resources
NYSE
UCP
UCP, Inc.
LSE
MDS
Midas Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios